Pierre‐Louis Hervé

Author

Pierre‐Louis Hervé

Virologie et Immunologie Moléculaires ORCID

Also Known As

Hervé, Pierre-Louis, P HERVE, P Herve, P Hervé, P. HERVE, P. HERVÉ, P. Herve, P. Hervé, P.L. Hervé, Pierre-Louis Hervé

Publications

724

Citations

H-Index

Concepts

All Affiliations

Virologie et Immunologie Moléculaires DBV Technologies (France)Université Paris-Saclay Institut Pasteur Délégation Paris 7

About

Pierre‐Louis Hervé is an author at Virologie et Immunologie Moléculaires specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	540
2	Health Sciences	2	2	27
3	Engineering	1	1	54
4	Public Health	1	1	16
5	Allergy	1	1	10

Pierre‐Louis Hervé

Publications

642

Citations

H-Index

Page 1

	Year	Citations
Visualizing the replication of respiratory syncytial virus in cells and in living mice Marie‐Anne Rameix‐Welti, Ronan Le Goffic, Pierre‐Louis Hervé, Nature Communications Viral ReplicationMedicineViral PathogenesisVirologyLiving Mice	2014	145
Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity Dania Zhivaki, Sébastien Lemoine, Ahsen Morva, Immunity Inflammatory Lung DiseaseLung InflammationHuman NeonatesImmunologyAntiviral Response	2017	136
A Novel Subnucleocapsid Nanoplatform for Mucosal Vaccination against Influenza Virus That Targets the Ectodomain of Matrix Protein 2 Pierre‐Louis Hervé, Mariam Raliou, Christiane Bourdieu, Journal of Virology Novel Subnucleocapsid NanoplatformEngineeringN NanoringImmunologyFlu Vaccination	2013	54
Kinetic Characterization of PB1-F2-Mediated Immunopathology during Highly Pathogenic Avian H5N1 Influenza Virus Infection Olivier Leymarie, Grégory Jouvion, Pierre‐Louis Hervé, PLoS ONE VaccinationPb1-f2-mediated ImmunopathologyPathogenesisViral PathogenesisImmunology	2013	43
Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity Pierre‐Louis Hervé, Valérie Lorin, Grégory Jouvion, Virology VaccinationH5 HemagglutininGlobular HeadImmunologyViral Pathogenesis	2015	37
Humoral and cellular immunity in patients with hepatic alveolar echinococcosis. A 2 year follow‐up with and without flubendazole treatment Dominique A. Vuitton, A Lassègue, Jean‐Philippe Miguet, Parasite Immunology	1984	31
RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine Pierre‐Louis Hervé, Charlotte Deloizy, Delphyne Descamps, Nanomedicine Nanotechnology Biology and Medicine VaccinationNanomedicineCross-protectionVaccine DevelopmentVaccine Target	2016	31
Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept Pierre‐Louis Hervé, Delphyne Descamps, Charlotte Deloizy, Journal of Controlled Release ImmunologyNanomedicineCross-protectionVaccine TargetNon-invasive Epicutaneous Vaccine	2016	22
The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin Charlotte Deloizy, Even Fossum, Christophe Barnier-Quer, Scientific Reports	2017	20
Epidermal micro-perforation potentiates the efficacy of epicutaneous vaccination Pierre‐Louis Hervé, Véronique Dhelft, Camille Plaquet, Journal of Controlled Release VaccinationMedicineCutaneous BiologyTopical DrugWound Healing	2019	19

Page 1